bosentan anhydrous has been researched along with ramipril in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ardaillou, R; Chatziantoniou, C; Dussaule, JC; Pauti, MD; Tharaux, PL; Vassitch, Y | 1 |
| Antus, B; Fillinger, J; Horvath, I; Jeney, C; Sebe, A | 2 |
| Scott, D; Shandas, R; Stenmark, KR; Tan, W; Tan, Y | 1 |
1 review(s) available for bosentan anhydrous and ramipril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for bosentan anhydrous and ramipril
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Activation of renin synthesis is dependent on intact nitric oxide production.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bosentan; Calcium; Calcium Channel Blockers; Diuretics; Enzyme Inhibitors; Furosemide; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nicardipine; Nitric Oxide; Nitric Oxide Synthase; Ramipril; Rats; Rats, Sprague-Dawley; Renin; Sulfonamides | 1997 |
Effects of blockade of the renin-angiotensin and endothelin systems on experimental bronchiolitis obliterans.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bosentan; Bronchiolitis Obliterans; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelins; Gene Expression Regulation; Male; Necrosis; Platelet-Derived Growth Factor; Ramipril; Rats; Rats, Inbred BN; Rats, Inbred Lew; Receptors, Endothelin; Renin-Angiotensin System; RNA, Messenger; Sulfonamides; Trachea; Transforming Growth Factor beta1; Transplantation, Homologous | 2006 |
Late treatment with angiotensin-converting enzyme inhibitors plus endothelin receptor antagonists ameliorates rat tracheal allograft rejection.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bosentan; Bronchiolitis Obliterans; Endothelin Receptor Antagonists; Graft Rejection; Male; Polymerase Chain Reaction; Ramipril; Rats; Rats, Inbred BN; Rats, Inbred Lew; Sulfonamides; Trachea; Transplantation, Isogeneic | 2008 |
High pulsatility flow stimulates smooth muscle cell hypertrophy and contractile protein expression.
Topics: Actins; Animals; Bosentan; Cattle; Cells, Cultured; Coculture Techniques; Endothelial Cells; Hypertrophy; Mechanotransduction, Cellular; Myocytes, Smooth Muscle; Myosin Heavy Chains; Peptidyl-Dipeptidase A; Pulmonary Artery; Pulsatile Flow; Ramipril; Sulfonamides; Transforming Growth Factor beta1; Vascular Stiffness | 2013 |